PTGX Protagonist Therapeutics, Inc.

NASDAQ

$141.86

Protagonist Therapeutics, Inc. (PTGX) Earnings News

Earnings press releases, previews and reviews for Protagonist Therapeutics, Inc. (PTGX), newest first.